BCAB · BioAtla, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plan, and along with our history of operating losses, our current cash and cash equivalents are not sufficient to fund our ongoing operations for a period of at least twelve months from the date the condensed consolidated financial statements included in this report are issued, and these circumstances raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-31 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. |
Common Stock
|
134 |
| 2026-05-31 | Vasquez Christian |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. |
Common Stock
|
82 |
| 2026-05-31 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. |
Common Stock
|
259 |
| 2026-03-12 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. |
Common Stock
|
639 |
| 2026-03-11 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. |
Common Stock
|
360 |
| 2026-03-11 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date. |
Common Stock
|
430,000 |
| 2026-03-11 | Vasquez Christian |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. |
Common Stock
|
175 |
| 2026-03-10 | Sievers Eric |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 10, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date. |
Common Stock
|
240,000 |
| 2026-03-10 | Vasquez Christian |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 10, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date. |
Common Stock
|
240,000 |
| 2026-02-28 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
7,728 |
| 2026-02-28 | WALDRON RICHARD A |
Former Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,729 |
| 2026-02-28 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
3,140 |
| 2026-02-28 | Vasquez Christian |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
1,802 |
| 2025-11-30 | Vasquez Christian |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes shares purchased under the Issuer's ESPP. |
Common Stock
|
1,566 |
| 2025-11-30 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
6,347 |
| 2025-11-30 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,729 |
| 2025-11-30 | WALDRON RICHARD A |
Former Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes shares purchased under the Issuer's ESPP. |
Common Stock
|
2,371 |
| 2025-08-31 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,729 |
| 2025-08-31 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
6,347 |
| 2025-08-31 | WALDRON RICHARD A |
Former Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,371 |
| 2025-08-31 | Vasquez Christian |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
1,566 |
| 2025-06-18 | MCBRINN SYLVIA |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
23,500 |
| 2025-06-18 | GRAY MARY ANN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
23,500 |
| 2025-06-18 | Smith Scott Andrew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
23,500 |
| 2025-06-18 | Williams Eddie |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
23,500 |
| 2025-06-18 | STEINMAN LAWRENCE |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
23,500 |
| 2025-06-18 | Moran Susan |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
23,500 |
| 2025-05-31 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
6,347 |
| 2025-05-31 | WALDRON RICHARD A |
Former Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes shares purchased under the Issuer's ESPP Plan. |
Common Stock
|
2,371 |
| 2025-05-31 | Vasquez Christian |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes shares purchased under the Issuer's ESPP Plan. |
Common Stock
|
1,566 |
| 2025-05-31 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,729 |
| 2025-03-12 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider. |
Common Stock
|
431,000 |
| 2025-03-11 | WALDRON RICHARD A |
Former Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider. |
Common Stock
|
100,000 |
| 2025-03-11 | Sievers Eric |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider. |
Common Stock
|
175,000 |
| 2025-03-11 | Vasquez Christian |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider. |
Common Stock
|
85,000 |
| 2025-02-16 | SHORT JAY M PHD |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
30,911 |
| 2025-02-15 | WALDRON RICHARD A |
Former Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes shares purchased under the Issuer's ESPP Plan. |
Common Stock
|
10,887 |
| 2025-02-15 | Vasquez Christian |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes shares purchased under the Issuer's ESPP Plan. |
Common Stock
|
7,189 |
| 2025-02-15 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
12,530 |
| 2024-08-31 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
572 |
| 2024-08-31 | Smith Scott Andrew |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,181 |
| 2024-07-31 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
572 |
| 2024-07-31 | Smith Scott Andrew |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,181 |
| 2024-06-30 | Smith Scott Andrew |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
2,181 |
| 2024-06-30 | Sievers Eric |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Common Stock
|
572 |
| 2024-06-13 | GRAY MARY ANN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
16,500 |
| 2024-06-13 | Moran Susan |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
16,500 |
| 2024-06-13 | MCBRINN SYLVIA |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
16,500 |
| 2024-06-13 | Williams Eddie |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
16,500 |
| 2024-06-13 | Smith Scott Andrew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Common Stock
|
16,500 |